1-9 of 9
Antonio Jimenez-Velasco, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy Profile of Asciminib As Treatment in Chronic Myeloid Leukemia Patients after Several Tyrosine-Kinase Inhibitors Failure

Alejandro Luna, MD, Natalia Estrada, Concepcion Boque, MD PhD, Blanca Xicoy, MD, Pilar Giraldo, PhD, Anna Angona, Alberto Alvarez-Larrán, MD PhD, Fermin Sanchez-Guijo, MD PhD, María José Ramírez, Juan M. Alonso-Domínguez, Elvira Mora, Patricia Vélez, MD, Ana Rosell, Mercedes Colorado Araujo, Beatriz Cuevas, MD, Miguel Sagüés, Montserrat Cortes, Manuel Perez Encinas, MD, Luis Felipe Casado Montero, MD, Melania Moreno Vega, Luis Serrano, Valle Gomez, Carmen Garcia-Hernandez, MD, Sunil Lakhwani Lakhwani, Antonio Paz Coll, Raquel de Paz, MD, Sara Suarez-Varela, Andrés Fernandez-Ruiz, Raul Perez Lopez, Almudena Ortiz-Fernández, Antonio Jiménez-Velasco, MD, Valentín Garcia-Gutiérrez, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-138690
Published: 2020
Journal Articles

Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION

Massimo Breccia, MD, Michael J. Mauro, MD, Elias Jabbour, MD, Giuseppe Saglio, MD PhD, Antonio Jiménez-Velasco, MD, Philipp D le Coutre, MD, Irene DeGutis, PharmD, Wasiulla Khan, PhD, Oumar Sy, PhD, Rene Swanink, Jorge E. Cortes, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-137636
Published: 2020
Journal Articles

Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial

Massimo Breccia, MD, Jorge E. Cortes, MD, Neil P Shah, MD PhD, Giuseppe Saglio, MD, Antonio Jiménez-Velasco, MD, Philipp Le Coutre, MD, Alexander Brun, PharmD, Irene DeGutis, Sai Bathena, Oumar Sy, PhD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4155.
https://doi.org/10.1182/blood-2019-121872
Published: 2019
Journal Articles

Updated 18-Month Results from Dasfree: A Study Evaluating Dasatinib Discontinuation in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)

Neil P. Shah, MD PhD, Jose Valentín García Gutiérrez, MD PhD, Antonio Jiménez-Velasco, MD, Sarah Larson, MD, Susanne Saussele, MD, Delphine Rea, MD, François-Xavier Mahon, MD PhD, Moshe Yair Levy, MD, María Teresa Gómez-Casares, MD PhD, Fabrizio Pane, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Oumar Sy, PhD, Patricia Martin Regueira, MD, Jeffrey H. Lipton, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4253.
https://doi.org/10.1182/blood-2018-99-116563
Published: 2018
Journal Articles

Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)

Neil P. Shah, MD PhD, Jose Valentín García Gutiérrez, PhD, Antonio Jiménez-Velasco, MD, Sarah M Larson, MD, Susanne Saussele, MD, Delphine Rea, MD, François-Xavier Mahon, MD PhD, Moshe Levy, MD, María Teresa Gómez-Casares, MD PhD, Fabrizio Pane, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Oumar Sy, PhD, Patricia Martin-Regueira, MD, Jeffrey H. Lipton, PhD MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 314.
https://doi.org/10.1182/blood.V130.Suppl_1.314.314
Published: 2017
Journal Articles

Treatment-Free Remission (TFR) in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) and in Stable Deep Molecular Response (DMR) to Dasatinib - the Dasfree Study

Neil P. Shah, MD PhD, Ronald Paquette, MD, Martin C. Müller, MD, Susanne Saussele, MD, Valentin Garcìa-Gutiérrez, MD, Antonio Jiménez-Velasco, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Francois-Xavier Mahon, MD PhD, Delphine Rea, MD PhD, Patricia Martin-Regueira, MD, Milayna Subar, MD, Li Li, PhD, Jeffrey H. Lipton, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1895.
https://doi.org/10.1182/blood.V128.22.1895.1895
Published: 2016
Journal Articles

The Molecular Response at 3 Months, Measured Using a Genxpert Platform, Predicts Further Outcomes in Chronic Myeloid Patients, but the Cutoff Differs from the 10% Cutoff Commonly Used with the EUTOS Method

Valentín García Gutiérrez, María Teresa Gómez-Casares, Jose Manuel Puerta, Juan Manuel Alonso, Santiago Osorio, Juan Carlos Hernández-Boluda, Rosa Collado, Maria Jose Ramirez, MD, Fatima Ibañez, MD, Maria Luisa Martin, Juan Diego Rodriguez, Carolina Martinez-Laperche, Montse Gomez, Viviana Fiallo, Redondo Sara, Alicia Rodriguez, Concepcion Ruiz, Juan Luis Steegmann, MD, Antonio Jiménez-Velasco, MD
Journal: Blood
Blood (2016) 128 (22): 1906.
https://doi.org/10.1182/blood.V128.22.1906.1906
Published: 2016
Journal Articles

The Use of Imatinib with Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation Improves Survival of Philadelphia Positive Acute Lymphoblastic Leukemia in Adults

Josefina Perez-Nuñez, MD, Antonio Jimenez-Velasco, MD, Katy Hurst, MD, Manuel Barrios-Garcia, MD PhD, MJ Moreno, MD, Ana Isabel Heiniger Mazo, MD
Journal: Blood
Blood (2014) 124 (21): 3653.
https://doi.org/10.1182/blood.V124.21.3653.3653
Published: 2014
Journal Articles

Improved Prediction of Acute Leukemia Relapse after Allogeneic SCT by Chimerism Analysis of Null Alleles and Indel Polymorphisms with Real-Time Quantitative PCR.

Antonio Jimenez-Velasco, MD, Manuel Barrios, MD, PhD, Jose Roman-Gomez, MD, PhD, German Navarro, PhD, Ismael Buño, PhD, Jose L. Diez-Martin, MD, PhD, Antonio Torres, MD, PhD, Ana I. Heiniger, MD
Journal: Blood
Blood (2004) 104 (11): 1650.
https://doi.org/10.1182/blood.V104.11.1650.1650
Published: 2004